LENZ Therapeutics annual return on equity
2021
2022
2024
2025
LENZ Therapeutics Return on Equity (ROE) Growth & History (LENZ)
LENZ Therapeutics's return on equity was −33.63% for fiscal 2025.
View full LENZ Therapeutics company overviewLENZ Therapeutics annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −33.63% | +55.74 pp |
| 2024 | 2024-12-31 | −89.37% | — |
| 2022 | 2022-12-31 | −56.16% | −11.75 pp |
| 2021 | 2021-12-31 | −44.41% | — |
LENZ Therapeutics quarterly return on equity
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −13.71% | −6.22 pp |
| Q1 2026 | 2026-03-31 | −15.63% | −8.25 pp |
| Q4 2025 | 2025-12-31 | −15.01% | −8.98 pp |
| Q3 2025 | 2025-09-30 | −8.34% | −3.34 pp |
| Q2 2025 | 2025-06-30 | −7.49% | −2.24 pp |
| Q1 2025 | 2025-03-31 | −7.38% | +24.19 pp |
| Q4 2024 | 2024-12-31 | −6.03% | — |
| Q3 2024 | 2024-09-30 | −5.00% | — |
| Q2 2024 | 2024-06-30 | −5.24% | — |
| Q1 2024 | 2024-03-31 | −31.57% | — |
| Q4 2022 | 2022-12-31 | −16.83% | −12.00 pp |
| Q3 2022 | 2022-09-30 | −7.54% | −3.79 pp |
| Q2 2022 | 2022-06-30 | −7.41% | +3.76 pp |
| Q1 2022 | 2022-03-31 | −6.93% | — |
| Q4 2021 | 2021-12-31 | −4.83% | — |
| Q3 2021 | 2021-09-30 | −3.74% | — |
| Q2 2021 | 2021-06-30 | −11.17% | — |
LENZ Therapeutics return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, LENZ Therapeutics's return on equity increased from −44.41% to −33.63%, a change of +10.78 percentage points. The latest reported quarter, Q2 2026, shows −13.71%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LENZ Therapeutics source filings ↗